You are here

Article info

Article menu

Download PDFPDF

XML
Basic tumor immunology
Original research
Endogenous TLR2 ligand embedded in the catalytic region of human cysteinyl-tRNA synthetase 1

Authors

  • Seongmin Cho Medicinal Bioconvergence Research Center and College of Pharmacy, Seoul National University, Suwon, South Korea Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, and College of Pharmacy, Seoul National University, Seoul, South Korea PubMed articlesGoogle scholar articles
  • Sang Bum Kim Medicinal Bioconvergence Research Center and College of Pharmacy, Seoul National University, Suwon, South Korea Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, and College of Pharmacy, Seoul National University, Seoul, South Korea PubMed articlesGoogle scholar articles
  • Youngjin Lee Infection and Immunity Research Laboratory, Metabolic Regulation Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, South Korea PubMed articlesGoogle scholar articles
  • Ee Chan Song Medicinal Bioconvergence Research Center and College of Pharmacy, Seoul National University, Suwon, South Korea Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, and College of Pharmacy, Seoul National University, Seoul, South Korea PubMed articlesGoogle scholar articles
  • Uijoo Kim Medicinal Bioconvergence Research Center and College of Pharmacy, Seoul National University, Suwon, South Korea Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, and College of Pharmacy, Seoul National University, Seoul, South Korea PubMed articlesGoogle scholar articles
  • Hyeong Yun Kim Medicinal Bioconvergence Research Center and College of Pharmacy, Seoul National University, Suwon, South Korea Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, and College of Pharmacy, Seoul National University, Seoul, South Korea PubMed articlesGoogle scholar articles
  • Ji Hun Suh Medicinal Bioconvergence Research Center and College of Pharmacy, Seoul National University, Suwon, South Korea Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, and College of Pharmacy, Seoul National University, Seoul, South Korea PubMed articlesGoogle scholar articles
  • Peter C Goughnour Medicinal Bioconvergence Research Center and College of Pharmacy, Seoul National University, Suwon, South Korea PubMed articlesGoogle scholar articles
  • YounHa Kim Medicinal Bioconvergence Research Center and College of Pharmacy, Seoul National University, Suwon, South Korea PubMed articlesGoogle scholar articles
  • Ina Yoon Medicinal Bioconvergence Research Center and College of Pharmacy, Seoul National University, Suwon, South Korea PubMed articlesGoogle scholar articles
  • Na Young Shin Medicinal Bioconvergence Research Center and College of Pharmacy, Seoul National University, Suwon, South Korea PubMed articlesGoogle scholar articles
  • Doyeun Kim Medicinal Bioconvergence Research Center and College of Pharmacy, Seoul National University, Suwon, South Korea PubMed articlesGoogle scholar articles
  • Il-Kyu Kim Laboratory of Immunology, Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul, South Korea PubMed articlesGoogle scholar articles
  • Chang-Yuil Kang Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, and College of Pharmacy, Seoul National University, Seoul, South Korea Laboratory of Immunology, Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul, South Korea PubMed articlesGoogle scholar articles
  • Song Yee Jang Infection and Immunity Research Laboratory, Metabolic Regulation Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, South Korea PubMed articlesGoogle scholar articles
  • Myung Hee Kim Infection and Immunity Research Laboratory, Metabolic Regulation Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, South Korea PubMed articlesGoogle scholar articles
  • Sunghoon Kim Medicinal Bioconvergence Research Center and College of Pharmacy, Seoul National University, Suwon, South Korea Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, and College of Pharmacy, Seoul National University, Seoul, South Korea PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Sunghoon Kim; sungkim{at}biocon.snu.ac.kr
View Full Text

Citation

Cho S, Kim SB, Lee Y, et al
Endogenous TLR2 ligand embedded in the catalytic region of human cysteinyl-tRNA synthetase 1
Journal for ImmunoTherapy of Cancer 2020;8:e000277. doi: 10.1136/jitc-2019-000277

Publication history

  • Accepted April 24, 2020
  • First published May 26, 2020.
Online issue publication 
January 11, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.